Ferritin, lactoferrin and transferrin are the three major iron-binding proteins in man. Until recently the clinical interest for these proteins was mainly confined to their role in iron transport and/or storage.
Nevertheless, increased serum ferritin concentrations have been found in a wide variety of malignant states including Hodgkin's disease, leukaemia, carcinoma of breast, pancreas, stomach and colonrectum.6 8 10 12 19 Metabolic disorders in mononuclear phagocytic cells, lymphocytes or macrophages synthesis, tissue damage and tumour synthesis have been suggested as an explanation for this increase in ferritin serum concentrations in malignancy.2 6 810 12 15 17 21 22 On the other hand, raised transferrin serum concentrations and transferrin receptors have been demonstrated in breast carcinoma.3 5 1116 Lactoferrin, like transferrin, is considered to play an important role in iron transport in human breast and other glandular tissues.13 14 20 In a previous study,'3 transferrin was found, by an After each incubation, the slides were washed with Tris-saline and placed in Tris-buffer for 20 min. The sites of antibody binding are shown by developing the peroxidase reaction with diaminobenzidine according to Weir.23 The slides were then washed with water, counterstained with haematoxylin, dehydrated and mounted in Entellan. The specificity of the immunohistochemical method was confirmed by the negative results obtained after omission and replacement of the antisera, and by neutralisation studies using antisera adsorbed with human ferritin and lactoferrin (Calbiochem-Behring).
Results
The results are summarised in the rounding neoplastic tissues, intensive and frequent positivities were detected in all cases, mainly located in the cytoplasm of histiocytes and spindle-shaped cells. Globular ferritin deposits were also detected in connectival stroma. In areas of normal and dysplastic mammary tissue, spindle-shaped transferrin positive cells were sometimes arranged in a discontinuous layer at the periphery of ductules and ducts. Similar findings were often observed in ductal in situ carcinoma. In other carcinoma types, only occasional spindleshaped transferrin positive cells were detectable among neoplastic cells. In connectival stroma, histiocytic cells frequently displayed transferrin positivities with varying intensity and frequency. In eight invasive ductal carcinoma, a strong transferrin staining was observed in a variable number (10-50%) of neoplastic cells.
Lactoferrin staining was often observed in the secretory material within the lumina, and in the cytoplasm of ductules and intralobular duct epithelial cells in areas of normal and dysplastic tissue. The higher staining intensity was mainly detected in the supranuclear region and at the cellular apex. The mammary epithelium with apocrine metaplasia was constantly negative, whereas epithelial cells in fibroadenoma and in adenosic areas displayed rare and weak positivities. In carcinomas, the immunoperoxidase staining was not observed in neoplastic cells. Only polymorphs among neoplastic cells showed strong intracytoplasmic staining.
Discussion and conclusions
Evidence for the synthesis of ferritin by lymphocytes and mononuclear-phagocytic cells was previously reported.2 15 17 Raised serum ferritin concentrations in malignancy as well as in rheumatoid arthritis might reflect an increase in ferritin synthesis, or a metabolic Rossiello, Carriero, Giordano disorder in mononuclear-phagocytes cells, which accumulate ferritin though a reduction of serum iron and of transferrin saturation may occur.8 10 15 Our findings confirm this possibility since ferritin staining has been mostly observed in connectival stroma and macrophagic cells surrounding neoplastic tissue. Ferritin staining was seldom observed in neoplastic cells and only in half of carcinoma cases. Other workers, on the contrary, have suggested that hyperferritinaemia might be due to tumour synthes 6 919 21 22 Nevertheless few immunohistochemical data have been reported in the literature: ferritin has been demonstrated in embryonal carcinoma cells by immunofluorescence21 and in carcinoma-in-situ of the testes by immunoperoxidase. 9 It has long been known that ferritins are a family of isomeric proteins containing two subunits, termed H and L, in different proportions.1 6 12 H subunit is found predominantly in the so-called acidic isoferritins, which are detectable in the heart, tumours, and HeLa cells. Basic isoferritins, on the other hand, contain prevalently L subunits and are usually detectable in the liver and spleen tissues. The antiserum employed by us (Dako) has been raised in rabbit with human liver and spleen ferritins as immunising antigens.
Consequently, this antiserum shows a lesser reactivity for the more acidic tumour isoferritins.1 The faint ferritin staining in neoplastic cells, as detected in the present study, might be attributed to this lower reactivity.
An unexplained, prevailing transferrin localisation in myoepithelial cells has been reported.13 In the present study, this peculiar localisation appeared to be inconstant and non-specific, since transferrin staining was also detected in stromal histiocytes. In addition the presence of transferrin positivities in neoplastic cells of eight carcinoma is very intriguing. Transferrin has been identified as an obligate growing factor in serum-free conditions.7 Transferrin receptors have also been considered to be a potential marker for identifying cells undergoing divisional activity and requiring the incorporation of additional iron.5 16 Therefore, it is tempting to speculate that transferrin staining may occur only in carcinoma and in neoplastic cells with high mitotic activity. Further studies are required to clarify these possible relations.
In the case of lactoferrin, our findings in normal breast epithelium appear to be in agreement with several papers which have provided immunohistochemical evidence for the presence of this protein in glandular tissue of different organs. 13 14 20 The lack of lactoferrin staining in all of 40 breast carcinoma suggests that this protein might be considered as a potential marker of benign lesions.
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